Skip to Content
Merck
  • Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne.

Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne.

The Journal of dermatological treatment (2012-11-21)
Fatma Cetinözman, Duygu Yazgan Aksoy, Gonca Elçin, Bulent O Yıldız
ABSTRACT

Androgens appear to play a role in the development of acne, and presence of acne is a potential marker of hyperandrogenism. The authors evaluated androgens and insulin sensitivity markers before and after treatment with isotretinoin in women with post-adolescent severe acne who do not have hirsutism and/or ovulatory dysfunction. Androgens, lipids, glucose and insulin levels were measured in 26 patients and 21 controls during oral glucose tolerance test. Homeostasis model assessment for insulin resistance, area under curve (AUC)glucose and AUCinsulin were calculated. Twenty patients completed a minimum of 6-month isotretinoin treatment. All studied parameters were similar in patients and controls at baseline. Isotretinoin therapy increased body mass index and triglyceride levels without any effect on androgens or insulin sensitivity. Severe acne itself is not associated with hyperandrogenemia and/or insulin resistance. Isotretinoin treatment does not alter serum androgens or insulin sensitivity, although it increases body weight and serum triglycerides.

MATERIALS
Product Number
Brand
Product Description

Supelco
Isotretinoin, Pharmaceutical Secondary Standard; Certified Reference Material
Isotretinoin, European Pharmacopoeia (EP) Reference Standard
USP
Isotretinoin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
13-cis-Retinoic acid, ≥98% (HPLC)